Petia Mitchell
Impact in
-
- Growth Hormone and Insulin-like Growth Factors
-
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Cancer, Hypoxia, and Metabolism 8
-
- Growth Hormone and Insulin-like Growth Factors 7
- Co-authors
- Pedro J. Beltran (11 shared papers)Frank J. Calzone (8 shared papers)Elaina Cajulis (8 shared papers)Robert Radinsky (7 shared papers)Richard Kendall (4 shared papers)Steven Vonderfecht (3 shared papers)Brian Belmontes (4 shared papers)Gordon Moody (5 shared papers)
- Journals
- Molecular Cancer Therapeutics (4 papers)Journal for ImmunoTherapy of Cancer (3 papers)Clinical Cancer Research (2 papers)Journal of Endocrinology (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Petia Mitchell
13 papers receiving 375 citations
Peers
Comparison fields: 5 of 42
- Endocrinology, Diabetes and Metabolism 131
- Oncology 185
- Cancer Research 75
- Genetics 92
- Immunology 65
Countries citing papers authored by Petia Mitchell
This map shows the geographic impact of Petia Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petia Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petia Mitchell more than expected).
Fields of papers citing papers by Petia Mitchell
This network shows the impact of papers produced by Petia Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petia Mitchell. The network helps show where Petia Mitchell may publish in the future.
Co-authors
The 25 scholars most cited alongside Petia Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 113 | |
| 2 | 2017 | 81 | |
| 3 | 2011 | 65 | |
| 4 | 2014 | 41 | |
| 5 | 2013 | 28 | |
| 6 | 2014 | 19 | |
| 7 | 2023 | 8 | |
| 8 | 2015 | 7 | |
| 9 | AMG 479, a fully human anti IGF-1 receptor monoclonal antibody, is efficacious against Ewing’s sarcoma and osteosarcoma xenografts | 2007 | 6 |
| 10 | Inhibition of endocrine IGF-1 signaling in normal murine tissues and human tumor xenografts with AMG 479, a fully human anti IGF-1R monoclonal antibody | 2007 | 4 |
| 11 | 2016 | 4 | |
| 12 | 2015 | 3 | |
| 13 | 2009 | 1 |
About Petia Mitchell
Petia Mitchell is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism, Molecular Biology, Genetics and Immunology, having authored 13 papers that have together received 380 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (8 papers), Growth Hormone and Insulin-like Growth Factors (7 papers), Virus-based gene therapy research (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (2 papers), Herpesvirus Infections and Treatments (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (131 citations), Oncology (185 citations), Cancer Research (75 citations), Genetics (92 citations) and Immunology (65 citations). Petia Mitchell has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Pedro J. Beltran, Frank J. Calzone, Elaina Cajulis, Robert Radinsky, Richard Kendall, Steven Vonderfecht, Brian Belmontes, Gordon Moody, John Lu and Joanne Ho. Their work appears in journals such as Molecular Cancer Therapeutics, Journal for ImmunoTherapy of Cancer, Clinical Cancer Research, Journal of Endocrinology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.